Serum ferritin, cardiovascular risk factors and ischaemic heart diseases: A prospective analysis in the SU.VI.MAX (SUpplementation en VItamines et Minéraux AntioXydants) cohort

Public Health Nutrition

Volumn 9, Issue 1, 2006, Pages 70-74

  Galan, Pilar ^a   Noisette, Nathalie ^a   Estaquio, Carla ^a   Czernichow, Sebastien ^a   Mennen, Louise ^a   Renversez, Jean Charles ^b   Briançon, Serge ^c   Favier, Alain ^b,d   Hercberg, Serge ^a,e  

^a INSERM   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d CNRS   (France)

^e Bioinformatique et Chimie Moléculaire   (France)

Author keywords

Iron; Ischaemic heart disease; Prospective study; Serum ferritin

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CHOLESTEROL; FERRITIN; HEMOGLOBIN; IRON; PLACEBO; SATURATED FATTY ACID; SELENIUM; TRIACYLGLYCEROL; ZINC;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; FOOD INTAKE; FRANCE; HUMAN; INCIDENCE; INTERVIEW; ISCHEMIC HEART DISEASE; MALE; NETHERLANDS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FERRITINS; FRANCE; HEMOGLOBINS; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 33645230958     PISSN: 13689800     EISSN: None     Source Type: Journal    
DOI: 10.1079/PHN2005826     Document Type: Article

References (44)

1. Halliwell B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Archives of Biochemistry and Biophysics 1986; 246: 501-14.
2. Sempos CT, Looker AC, Gillum RF. Iron and heart disease: the epidemiologic data. Nutrition Reviews 1996; 54: 73-84.
3. Meyers DG. The iron hypothesis: does iron cause atherosclerosis? Clinical Cardiology 1996; 19: 925-9.
4. Sempos CT. Do body iron stores increase the risk of developing coronary heart disease? American Journal of Clinical Nutrition 2002; 76: 501-3.
5. Ma J, Stampfer MJ. Body iron stores and coronary heart disease. Clinical Chemistry 2002; 48: 601-3.
6. Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. American Journal of Clinical Nutrition 1974; 27: 681-7.
7. Bozzini C, Girelli D, Yinazzi E, Olivieri O, Stranieri C, Bassi A, et al. Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study. Clinical Chemistry 2002; 48: 622-8.
8. Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Annals of Epidemiology 2000; 10: 441-8.
9. Aronow WS. Serum ferritin is not a risk factor for coronary artery disease in men and women aged >62 years. American Journal of Cardiology 1993; 72: 347-8.
10. Solymoss BC, Marcil M, Gilfix BM, Gelinas F, Poitras AM, Campeau L. The place of ferritin among risk factors associated with coronary artery disease. Coronary Artery Disease 1994; 5: 231-5.
11. Rauramaa R, Väisänen S, Mercuri M, Rankinen T, Penttila I, Bond MG. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged Eastern Finnish men. European Heart Journal 1994; 15: 1020-7.
12. Duthie GG, Beattie JAG, Arthur JR, Franklin M, Morrice PC, James WPT. Blood antioxidants and indices of lipid peroxidation in subjects with stable angina. Nutrition 1994; 10: 313-31.
13. Rengström J, Tonrvall P, Kallner A, Nilsson J, Hamsten A. Stored iron levels and myocardial infarction at a young age. Atherosclerosis 1994; 106: 123-5.
14. Moore M, Folsom AR, Barnes RW, Eckfeldt JH. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology 1995; 141: 719-23.
15. van der Schouw YT, Verbeek A, Ruijs J. ROC curves for the initial assessment of new diagnostic tests. Family Practice 1992; 9: 506-11.
16. Eichner JE, Qi H, Moore WE, Schechter E. Iron measures in coronary angiography patients. Atherosclerosis 1998; 136: 241-5.
17. Wolff B, Volzke H, Ludemann J, Robinson D, Vogelgesang D, Staudt A, et al. Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP). Stroke 2004; 35: 453-7.
18. Kiechl S, Aichner F, Gerstenbrand F, Egger G, Mair A, Rungger G, et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997; 96: 3300-7.
19. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86: 803-11.
20. Salonen JT, Nyyssonen K, Salonen R. Body iron stores and the risk of coronary heart disease [letter]. New England Journal of Medicine 1994; 331: 1159.
21. Stampfer MJ, Grodstein F, Rosenberg I, Willett WC, Hennekens CH. A prospective study of plasma ferritin and risk of myocardial infarction in US physicians [abstract]. Circulation 1993; 87: 10.
22. Manttari M, Manninen V, Huttunen JK, Palosuo T, Ehnholm C, Heinonen OP, et al. Serum ferritin and ceruloplasmin as coronary risk factors. European Heart Journal 1994; 15: 1599-603.
23. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson M, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994; 89: 102-8.
24. Frey GH, Krider DW. Serum ferritin and myocardial infarct. West Virginia Medical Journal 1994; 90: 13-5.
25. Baer DM, Tekawa IS, Hurley LB. Iron stores are not associated with acute myocardial infarction. Circulation 1994; 89: 2915-8.
26. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. New England Journal of Medicine 1994; 330: 1119-24.
27. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: negative findings from the NHANES I epidemiologic follow-up study. American Journal of Epidemiology 1994; 139: 704-12.
28. Reunanen A, Takkunen H, Knekt P, Seppanen R, Aromaa A. Body iron stores, dietary iron intake and coronary heart disease mortality. Journal of Internal Medicine 1995; 238: 223-30.
29. van Asperen IA, Feskens EJM, Bowles CH, Kromhout D. Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women. International Journal of Epidemiology 1995; 24: 665-70.
30. Morrison HI, Semenciw RM, Mao Y, Wigle DT. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 1994; 5: 243-6.
31. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation 1994; 89: 969-74.
32. Knuiman MW, Divitini ML, Olynyk JK, Cullen DJ, Bartholomew HC. Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia. American Journal of Epidemiology 2003; 158: 144-9.
33. Galan P, Yoon H-C, Preziosi P, Viteri F, Valeix P, Fieux B, et al. Determining factors in the iron status of adult women in the SU.VI.MAX study. European Journal of Clinical Nutrition 1998; 52: 383-8.
34. Hercberg S, Preziosi P, Briançon S, Galan P, Paul-Dauphin A, Malvy D, et al. A primary prevention trial of nutritional doses of antioxidant vitamins and minerals on cardiovascular diseases and cancers in general population: The SU.VI.MAX Study. Design, methods and participant characteristics. Controlled Clinical Trials 1998; 19: 336-51.
35. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SUVI MAX study: a randomised, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine 2004; 164: 1-8.
36. World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems, 10th version. Geneva: WHO, 1992.
37. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981; 1: 1293-4.
38. Danesh J, Appleby P. Coronary heart disease and iron status. Meta-analyses of prospective studies. Circulation 1999; 99: 852-4.
39. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001; 103: 52-7.
40. Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997; 78: 188-93.
41. Salonen JT, Tuomainen TP, Salonen R, Lakka TA, Nyyssonen K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. American Journal of Epidemiology 1998; 148: 445-51.
42. Williams MJA, Poulton R, Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 2002; 165: 179-84.
43. Oshaug A, Bugge KH, Bjonnes CH, Borch-Iohnsen B, Neslein IL. Associations between serum ferritin and cardiovascular risk factors in healthy young men: a cross sectional study. European Journal of Clinical Nutrition 1995; 49: 430-8.
44. Halle M, Konig D, Berg A, Keul J, Baumstark MW. Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. Atherosclerosis 1997; 128: 235-40.